ICD-10 · PDGM grouping
U09 Post COVID-19 condition
The one code in the U09 family, with the PDGM clinical group, comorbidity subgroup and primary-position rule CMS assigns, read from the CMS grouper crosswalk v07.2.26 and the CDC FY2027 code file.
Codes in family
1
Can lead a claim
0
Cannot lead a claim
1
What CMS assigns to U09
This code is assigned no clinical group. It counts toward the 2019 Novel Coronavirus comorbidity subgroup. It cannot lead a claim. CMS attaches a code-first note to it.
- 2019 Novel Coronavirus
Code first
CMS grouper convention 168. Code first:
- chronic respiratory failure (J96.1-)
- loss of smell (R43.8)
- loss of taste (R43.8)
- multisystem inflammatory syndrome (M35.81)
- pulmonary embolism (I26.-)
- pulmonary fibrosis (J84.10)
- the specific condition related to COVID-19 if known, such as:
The U09 code
Descriptions are CDC’s FY2027 wording; where CMS’s grouper abbreviates one, its form is shown beneath.
| Code | Description | Primary position | Clinical group | Comorbidity subgroup |
|---|---|---|---|---|
| U09.9 | Post COVID-19 condition, unspecified | Cannot lead a claimPrincipal diagnosis not assigned to a clinical group | None | 2019 Novel Coronavirus |
Sources: CMS HH PPS Grouper Software v07.2.26, effective 2026-10-01, for the clinical group, comorbidity subgroup, code-first conventions and primary-position flags; CDC NCHS ICD-10-CM FY2027 code descriptions for the family title and code wording. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.
The monthly home health regs digest
What CMS changed, what's due next, and what to do about it — one email a month, no fluff. Read the first issue